Download presentation
Presentation is loading. Please wait.
Published byBlaze Perkins Modified over 9 years ago
1
Sorting out your Headache patients Dr John G Hughes BASH for FDA 20141
2
2
3
3
4
History Examination Dr John G Hughes BASH for FDA 20144
5
Tension type headache Migraine Cluster and other TACs Dr John G Hughes BASH for FDA 20145
6
Head/neck injury Subarachnoid haemorrhage CSF pressure – high or low Brain tumour Chemical – CO or medication Dr John G Hughes BASH for FDA 20146
7
Featureless Band like ache Mild photo/phonophobia/nausea Dr John G Hughes BASH for FDA 20147
8
Throbbing pain Sensitivity to stimuli Exacerbated by activity Associated features Aura? Dr John G Hughes BASH for FDA 20148
9
9
10
10
11
Nausea Photophobia Disability (functional impairment) 93% predictive for migraine Dr John G Hughes BASH for FDA 201411
12
Evolving neurological phenomenon Visual Speech Sensory Dr John G Hughes BASH for FDA 201412
13
Aspirin Triptans Avoid triggers Prophylaxis B Blockers Topiramate Tricyclics Dr John G Hughes BASH for FDA 201413
14
Very severe 30-120 min Agitation and autonomic features Mainly men Diurnal and seasonal synchronicity Dr John G Hughes BASH for FDA 201414
15
Dr John G Hughes BASH for FDA 201415
16
Dr John G Hughes BASH for FDA 201416
17
Triptan injections Steroids High flow 100% oxygen Prophylaxis Verapamil Lithium Dr John G Hughes BASH for FDA 201417
18
New onset headache >50 Increased severity =/- frequency Exacerbation with exertion/Valsalva Patient pressure Dr John G Hughes BASH for FDA 201418
19
BASH Guidelines www.bash.org.uk/guidelines/ www.bash.org.uk/guidelines/ 3 minute neurological examination www.youtube.com/watch?v=fgwN1P5PDaA www.youtube.com/watch?v=fgwN1P5PDaA SIGN Guidelines www.sign.ac.uk/guidelines/fultext/107/ www.sign.ac.uk/guidelines/fultext/107/ Dr John G Hughes BASH for FDA 201419
20
Dr John G Hughes BASH for FDA 201420
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.